HomeQLGN • NASDAQ
add
Qualigen Therapeutics Inc
Previous close
$4.17
Day range
$3.90 - $4.31
Year range
$3.34 - $29.44
Market cap
3.15M USD
Avg Volume
36.89K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 1.15M | -14.33% |
Net income | -1.79M | 50.94% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -1.27M | 53.31% |
Effective tax rate | 0.12% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 388.15K | -81.28% |
Total assets | 2.31M | -46.41% |
Total liabilities | 4.45M | -25.23% |
Total equity | -2.14M | — |
Shares outstanding | 736.43K | — |
Price to book | -1.07 | — |
Return on assets | -222.76% | — |
Return on capital | 191.37% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -1.79M | 50.94% |
Cash from operations | -1.80M | -293.59% |
Cash from investing | -1.25M | -129.57% |
Cash from financing | 3.32M | 854.39% |
Net change in cash | 269.47K | -94.14% |
Free cash flow | -2.46M | -322.89% |
About
Founded
1996
Headquarters
Website
Employees
4
